Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2,6-Difluoro-4-ethoxybenzoic acid is a chemical compound characterized by the molecular formula C9H7F2O3. It is a derivative of benzoic acid, distinguished by the presence of two fluorine atoms and an ethoxy group attached to its aromatic ring. This white to off-white crystalline powder, with a melting point in the range of 97-102 degrees Celsius, is primarily utilized in laboratory research and development.

916483-56-2

Post Buying Request

916483-56-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

916483-56-2 Usage

Uses

Used in Pharmaceutical Synthesis:
2,6-Difluoro-4-ethoxybenzoic acid is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs with potentially enhanced properties, such as improved efficacy or reduced side effects.
Used in Agrochemical Production:
In the agrochemical industry, 2,6-Difluoro-4-ethoxybenzoic acid is employed as an intermediate, facilitating the creation of new agrochemicals aimed at enhancing crop protection and yield.
Used in Materials Science:
2,6-Difluoro-4-ethoxybenzoic acid may be utilized in materials science applications, potentially contributing to the advancement of materials with specific properties, such as improved thermal stability or chemical resistance.
Used in Organic Chemistry Research:
As a crystalline powder, 2,6-Difluoro-4-ethoxybenzoic acid is used in organic chemistry for research purposes, allowing scientists to explore its reactivity and potential applications in various chemical reactions and processes.

Check Digit Verification of cas no

The CAS Registry Mumber 916483-56-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,6,4,8 and 3 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 916483-56:
(8*9)+(7*1)+(6*6)+(5*4)+(4*8)+(3*3)+(2*5)+(1*6)=192
192 % 10 = 2
So 916483-56-2 is a valid CAS Registry Number.

916483-56-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Ethoxy-2,6-difluorobenzoic acid

1.2 Other means of identification

Product number -
Other names 4-ethoxy-2,6-difluorobenzamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:916483-56-2 SDS

916483-56-2Relevant articles and documents

QUINAZOLINE DERIVATIVES

-

Page/Page column 12, (2010/07/08)

The invention provided a compound of formula (I) for use in the treatment of disease, in particular proliferative diseases such as cancer and for use in the preparation of medicaments for use in the treatment of proliferative diseases; the invention also

Synthesis and mesomorphic properties of two series of laterally fluorinated symmetric ester liquid crystals

Wei, Qiang,Yuan, Xiaotao,Zhang, Lipei,Wang, Liping,Yang, Huai,Wang, Yangbin

experimental part, p. 52 - 60 (2010/03/25)

Two series of symmetric ester liquid crystals (nAFBHQ and nADFBHQ) with lateral fluorine atoms have been synthesized. Their chemical structures were measured by FTIR, 1H NMR, and elemental analysis (EA). Their mesomorphic properties were investigated by d

Novel synthesis of differentially substituted 5,7-dialkoxyquinazolin-4-ones

Foote, Kevin M.,Hatter, Glenn

, p. 2575 - 2583 (2008/12/22)

The preparation of 7-ethoxy-5-fluoroquinazolin-4-one, starting from 3,5-difluorophenol, is described. Further reaction with alkoxide then gives differentially substituted 5,7-dialkoxyquinazolin-4-ones. Copyright Taylor & Francis Group, LLC.

QUINAZOLINES AND THEIR USE AS AURORA KINASE INHIBITORS

-

, (2010/11/25)

The invention provided a compound of formula (I) for use in the treatment of disease, in particular proliferative diseases such as cancer and for use in the preparation of medicaments for use in the treatment of proliferative diseases; the invention also

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 916483-56-2